Peer-influenced content. Sources you trust. No registration required. This is HCN.
Pharmacy Learning Network
GLP-1 agonists are increasingly recognized for their dual benefits in type 2 diabetes management and cardiovascular risk reduction, offering a multifaceted approach to patient care in an expanding global market.
Cardiology March 13th 2024
Cleveland Clinic Journal of Medicine
Metformin is emerging as a viable option for weight management in obese patients without diabetes, showing sustained weight loss effects and potential benefits in populations with prediabetes or undergoing antipsychotic treatment.
Endocrinology, Diabetes, Metabolism March 13th 2024
This article illustrates a case of bullosis diabeticorum, spotlighting the condition’s clinical presentation, diagnosis, and management, offering key insights for physicians in the early detection and care of this rare diabetic complication.
Dermatology March 13th 2024
Johns Hopkins Medicine
A recent study underscores the delicate balance required in thyroid hormone therapy for older adults, highlighting a clear association between thyrotoxicosis and heightened cognitive disorder risk.
Clinical Pharmacology March 12th 2024
MDLinx
AABP represents a significant yet under-recognized consequence of obesity, requiring a multidisciplinary treatment strategy that transcends conventional weight loss advice and addresses the intricate psychological and physical needs of affected individuals.
Endocrinology, Diabetes, Metabolism March 6th 2024
The Epoch Times
Stevia’s interaction with the liver and potential effects on gut microbiome composition highlight the complexity of its impact on human health, reinforcing the importance of a nuanced approach when recommending dietary choices.